Drug discovery and development – Page 36
-
Research‘Robot scientist’ speeds up drug discovery
Automated AI lab that learns and formulates hypotheses has identified promising anti-cancer and anti-malarial compounds
-
FeatureHigh hopes
Cannabinoids are finally coming out of the shadows and onto the shelves of pharmacies around the globe. Rachel Brazil reports
-
NewsBillion dollar package unveiled to fight antibiotic resistance
President Obama wants to almost double US funding to fight antibiotic resistant bacteria in 2016
-
News
Ebola vaccine shown to be safe in humans
GlaxoSmithKline vaccine will now be trialled in Liberia
-
NewsRoadmap to fast track Ebola vaccine development
Expert panel recommends developing multiple vaccines and targeting at risk groups
-
ResearchNew antibiotic could treat infection while dodging resistance problems
Technique to tap huge unexplored reservoir of natural products in soil microorganisms finds promising compound
-
FeatureMapping the mosquito
Uncovering how mosquitoes sniff out their human victims may lead to new tools to conquer malaria and dengue fever. Emma Davies reports
-
-
-
BusinessMerck & Co to buy antibiotics specialist Cubist
Pharma giant remains committed to $9.5bn deal despite key Cubist patents being invalidated by court ruling
-
News
Tufts’ $2.6bn drug development figure questioned
Details sought about how university determined cost of bringing a drug to market jumped 145% since 2003
-
NewsEbola vaccine passes first safety hurdle
Researchers hope to begin larger trials of its effectiveness in west Africa soon
-
OpinionProgress at the pace of the slowest
Chemistry is rarely the rate-limiting process in getting a drug to market, says Derek Lowe
-
News
US drug development costs surge
The price of developing new prescription drugs in the US has increased 145% since 2003, Tufts data shows
-
NewsUS agency fast-tracks Ebola vaccine development
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
-
-
Business
Actavis boosts antibiotics with Durata buyout
$820 million deal gives Actavis control of newly-approved intravenous antibiotic
-
FeaturePepping up antibiotics
Industry and academia are turning to antimicrobial peptides to find new antibiotics, Andy Extance discovers
-
FeatureChemistry in bloom
Sarah Houlton discovers the chemistry among the specimens at many botanical gardens
-
ResearchCoated nanoparticles show Alzheimer's promise
Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerative disease